Abbott Laboratories (ABT) Divestments (2015 - 2021)

Abbott Laboratories (ABT) posted Divestments of $86.0 million for Q3 2021, up 760.0% sequentially from $10.0 million in Q4 2020.

Abbott Laboratories (ABT) Divestments (2015 - 2021) Analysis & Trends

Abbott Laboratories has reported Divestments for 5 years, with the latest figure at $86.0 million in Q3 2021.

Quarterly Divestments changed N/A year-over-year to $86.0 million in Q3 2021, while the trailing twelve-month figure through Dec 2022 was $86.0 million (down 10.42% YoY) and the FY2024 annual result came in at $1.0 million, down 97.5% from the prior year.
Divestments grew to $86.0 million in Q3 2021 per ABT's latest filing, from $10.0 million in the prior quarter.
Over five years, Divestments peaked at $5.5 billion in Q1 2017 and troughed at -$29.0 million in Q3 2017.
A 3-year average of $1.0 billion and a median of $48.0 million in 2020 frame the typical range for Divestments.
The widest YoY moves for Divestments: up 21788.0% in 2017, down 21788.0% in 2017.
Over 3 years, Divestments stood at $600.0 million in 2017, then slumped by 98.33% to $10.0 million in 2020, then jumped by 760.0% to $86.0 million in 2021.
According to Business Quant data, Divestments over the past three periods registered $86.0 million, $10.0 million, and $600.0 million for Q3 2021, Q4 2020, and Q4 2017 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Abbott Laboratories	200.08 Bn	194.48 Bn	7.27 Bn	-
2	Stryker	129.71 Bn	126.23 Bn	4.50 Bn	-
3	Medtronic	120.07 Bn	110.85 Bn	6.41 Bn	-
4	Boston Scientific	74.08 Bn	73.54 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.68 Bn	48.43 Bn	1.35 Bn	-
6	Dexcom	34.51 Bn	32.56 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.03 Bn	31.92 Bn	2.18 Bn	-
8	Koninklijke Philips	26.51 Bn	23.19 Bn	4.55 Bn	153.43 Mn
9	Steris	23.20 Bn	22.72 Bn	684.20 Mn	-
10	Zimmer Biomet Holdings	19.37 Bn	18.96 Bn	1.54 Bn	-

Download Data